Description
Book SynopsisIn the fall of 1980, Genentech, Inc, a little-known California genetic engineering company, became the overnight darling of Wall Street, raising $38 million in its initial public stock offering. This title provides portraits of the people significant to Genentech's science and business, and focuses on how personality affects the growth of science.
Trade Review"Sally Smith Hughes has crafted an engaging historical account of Genentech from its beginnings as a small laboratory at the University of California, San Francisco to the 2009 merger with Roche for $47 billion.... Her account will appeal to a broad audience and is a must read for scholars interested in the history of biotechnology. Highly recommended." (Choice)"